Bristol-Myers Squibb Co (NYSE: BMY)

• Support level
  N/A
• Resistance level
  $56.17

• Beta
  0.3
• RSI (14-day)
  16.1

• BMY is one of this month's worst performers with a return of -18.5 percent, underperforming 90 percent of stocks in the S&P-100.
• Volatility is forecast to fall over the next month.
• BMY is below its 200-day moving average - additional caution warranted in long positions.
• With RSI < 30, BMY is oversold. Odds slightly favor a short-term price reversal.
• Price broke below prior support level - a short-term bearish signal.

Value at risk (VaR)

There is an estimated 5% probability that the stock price will fall by more than VaR in time period.

• In the next week
  9.2%
• In the next month
  15.3%
• In the next year
  58.3%